0001739410-24-000017.txt : 20240216
0001739410-24-000017.hdr.sgml : 20240216
20240216181850
ACCESSION NUMBER: 0001739410-24-000017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240215
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ryder Steven
CENTRAL INDEX KEY: 0001872868
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40693
FILM NUMBER: 24649965
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET, SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rallybio Corp
CENTRAL INDEX KEY: 0001739410
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851083789
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203- 859-3820
MAIL ADDRESS:
STREET 1: 234 CHURCH STREET
STREET 2: SUITE 1020
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
FORMER COMPANY:
FORMER CONFORMED NAME: Rallybio Holdings, LLC
DATE OF NAME CHANGE: 20180502
4
1
wk-form4_1708125519.xml
FORM 4
X0508
4
2024-02-15
0
0001739410
Rallybio Corp
RLYB
0001872868
Ryder Steven
C/O RALLYBIO CORPORATION
234 CHURCH STREET, SUITE 1020
NEW HAVEN
CT
06510
0
1
0
0
Chief Medical Officer
0
Option (Right to Buy)
1.86
2024-02-15
4
A
0
120000
0
A
2034-02-15
Common Stock
120000
120000
D
The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in 48 equal monthly installments until fully vested on February 15, 2028.
By: /s/ Michael Greco, Attorney-in-Fact
2024-02-16